Baycrest neuropsychologists have found that a smartphone training program, theory-driven and specifically designed for individuals with memory impairment, can result in "robust" improvements in day-to-day functioning, and boost independence and confidence levels. "The goal of our study was to demonstrate the generalizability of our training protocol to a larger number of individuals with moderate-to-severe memory impairment," said Dr. Eva Svoboda, a clinical neuropsychologist in the Neuropsychology and Cognitive Health Program at Baycrest. "Our findings demonstrate that it is possible to harness powerful emerging technologies with brain science in an innovative way to give people with a range of memory deficits some of their independence back." Memory impairment, particularly when it is severe, can impact virtually all aspects of everyday life. Individuals are unable to readily acquire new information making it difficult or impossible to keep appointments and stay on top of changing personal, social and occupational responsibilities.
In August of 2018, the Federal Minister of Justice approved the Drager Drug Test 5000 as the Approved Drug Screening Equipment (ADSE) for all Canadian police services. The device itself is costly ($6,000 per device, and $60 per swab) and has to be used under ideal conditions for proper analysis, according to experts. The device tests for commonly used drugs in oral fluids including THC, which is the major psychoactive component in cannabis. Although the device may excel at identifying presence of THC, it does not address the issue of impairment specially when studies do not support a strong correlation between THC levels and impairment. Currently, there's an urgent demand for a device to assist Canadian police officers in their drug impairment investigations which is where PredictMedix is likely to fill an unmet need.
Given the evidence against THC causing impairment, the implications are profound. Police and courts are confused by cases where cannabis testing is positive, yet sobriety testing is negative. Michelle Gray, a medical marijuana user, had her license suspended after a positive saliva test for cannabis, even though she passed a police-administered sobriety test the same night. Subsequently, Canadian police apologized to her for incorrectly suspending her licence for a week. Sobriety testing for cannabis comes under question.
Sony Corp. said it will book a write-down of ¥112.1 billion over losses related to its movie operations amid the anticipated shrinking of the DVD and Blu-ray Disc market. The electronics giant had forecast a ¥270 billion group operating profit and a ¥60 billion net profit for fiscal 2016 ending in March but is currently assessing the impact of the write-down, the company said Monday. Sony will announce the impairment loss Thursday when it releases its earnings for the April-December period. The impairment losses are related to Columbia Pictures Entertainment, now Sony Pictures Entertainment Inc., acquired in 1989. The write-down comes as the operations and assets of the movie subsidiary of Sony are of lower value than originally determined.
WASHINGTON – Memory loss may not always be the first warning sign that dementia is brewing -- changes in behavior or personality might be an early clue. Researchers on Sunday outlined a syndrome called "mild behavioral impairment" that may be a harbinger of Alzheimer's or other dementias, and proposed a checklist of symptoms to alert doctors and families. "Historically those symptoms have been written off as a psychiatric issue, or as just part of aging," said Dr. Zahinoor Ismail of the University of Calgary, who presented the checklist at the Alzheimer's Association International Conference in Toronto. Now, "when it comes to early detection, memory symptoms don't have the corner on the market anymore," he said. Alzheimer's, the most common form of dementia, affects more than 5 million people in the U.S., a number growing as the population ages.